- Nachrichtendetail
-
08.05.2024 14:04:17 - dpa-AFX: *ABBVIE : HEALTH CANADA APPROVES QULIPTA FOR PREVENTIVE TREATMENT OF CHRONIC MIGRAINE IN ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 173,280 | 20.09.24 17:35:30 | +0,120 | +0,07% | 0,000 | 0,000 | 173,340 | 173,280 |
